Sware Raises $6M to Accelerate Life Sciences Innovation by Automating FDA-Mandated Software Validation
Sware Receives SOC 2 Type II Certification
Sware is thrilled to announce that it has received a System and Organizational Controls 2 Type II (SOC 2 Type II) certification following a successful external audit by Sensiba LLP. This certification reflects Sware’s commitment to operating with the highest degree of technological rigor possible, to best serve customers, the patients they serve, and stakeholders at large.
Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2 information security audit provides a report on the examination of controls relevant to the trust services criteria categories covering security, availability and confidentiality. A SOC 2 Type II report describes a service organization's systems, whether the design of specified controls meets the relevant trust services categories and – as a follow-up to Type I – assesses the effectiveness of those controls over a specified period of time.
Critically, Sware’s SOC 2 Type II report did not have any noted exceptions and was therefore issued with a “clean” audit opinion from Sensiba. We are proud of the hard work our team accomplished to not only meet this standard, but to do so in an exceptional, transparent way.
We are excited to share this important news with you, which we plan to make public later this month.
Best Regards,
Stephanie Skipper
Head of Quality
TABLE OF CONTENTS
Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Featured Resources
The future of life sciences validation and compliance is not so far away. Already, we are seeing life sciences companies rush to integrate AI where possible, while at the same time striving to manage risk with fewer human and material resources available.
Read the WhitepaperLearn how Nuvolo is leveraging a combination of Sware's Res_Q Platform and expert resources to deliver a fully GxP compliant offering to the life sciences industry, enabling Nuvolo and their customers to meet business goals.
Read the case studyManual computer software validation processes cost life sciences organizations up to 30% in additional project budget. As companies struggle to keep up with a surge of app and software integrations, they incur validation debt: the mounting cost of stretched resources, blanket testing, and missed GxP requirements.
Download the EbookValidation to Sware by
Res_Q was built to serve the unique, complex requirements around CSV for GxP systems. Leverage our intelligent validation automation platform and our deep compliance expertise to your benefit — reach out today to schedule a no-pressure session — We’re here to help you.